Qiagen (QGEN) announced the U.S. regulatory clearance of the first in a series of QIAstat-Dx Gastrointestinal Panel tests for ...
Qiagen has received clearance from U.S. regulators to market its gastrointestinal-illness test.
NYSE:QGEN) QIAGEN secures U.S. clearance for first QIAstat-Dx mini gastrointestinal panel to support year-round outpatient care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback